Research and development in the field of potential small molecule drugs against diabetes
Diabetes is a chronic metabolic disease. It manifests itself in an increased concentration of sugar in the blood. This project is evaluating active substances for the treatment of diabetes.
Description
The project pursues research and development work in the field of potential active substances against diabetes. This involves evaluating the effect of small molecules for the treatment of diabetes. The potential active ingredients are derived from natural product extracts, which are characterized using medicinal chemistry.
Key Data
Projectlead
Co-Projectlead
Dr. Michael Adams (BACOBA AG)
Project partners
BACOBA AG
Project status
completed, 04/2013 - 03/2014
Funding partner
Third party
Project budget
182'000 CHF